BTIG Downgrades Globus Medical (GMED) to Neutral, 'we see shares as unable to outperform'
Tweet Send to a Friend
BTIG analyst Ryan Zimmerman downgraded Globus Medical (NYSE: GMED) from Buy to Neutral.The analyst comments "We are downgrading GMED from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
